CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the publication of a landmark study in which single molecule sequencing was used to provide a digital expression profile of a eukaryotic transcriptome. The research article, now appearing in the on-line edition of Nature Biotechnology, demonstrates the unparalleled accuracy, precision and sensitivity of the Helicos™ Digital Gene Expression (DGE) application combined with the power of the Helicos™ Genetic Analysis System. The article will appear in the July 8, 2009 print issue of Nature Biotechnology.
